Head and neck cancer-part 1: epidemiology, presentation, and preservation, Clin Otolaryngol, vol.36, issue.1, pp.65-68, 2011. ,
Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer, Head Neck, vol.35, issue.6, pp.819-825, 2013. ,
Optical techniques in diagnosis of head and neck malignancy, Oral Oncol, vol.42, issue.3, pp.221-228, 2006. ,
FluoSTIC: miniaturized fluorescence image-guided surgery system, J Biomed Opt, vol.17, issue.10, p.106014, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01131973
Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation, Mol Imaging, vol.9, issue.5, pp.237-255, 2010. ,
Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence, Head Neck, vol.26, issue.3, pp.205-215, 2004. ,
Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device, Head Neck, vol.29, issue.1, pp.71-76, 2007. ,
The role of narrow band imaging in early detection of head and neck cancer, Br J Oral Maxillofac Surg, vol.50, issue.2, pp.132-136, 2012. ,
Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial, J Clin Oncol, vol.28, issue.9, pp.1566-1572, 2010. ,
Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer, Am J Gastroenterol, vol.106, issue.5, pp.858-866, 2011. ,
Autofluorescence-guided surveillance for oral cancer, Cancer Prev Res (Phila), vol.2, issue.11, pp.966-974, 2009. ,
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody, Int J Cancer, 2013. ,
Near infrared fluorescence for image-guided surgery, Quant Imaging Med Surg, vol.2, issue.3, pp.177-187, 2012. ,
Molecular imaging for cancer diagnosis and surgery, Adv Drug Deliv Rev, 2013. ,
Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer -preliminary experience, Head Neck Oncol, vol.2, p.31, 2010. ,
Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer, J Dermatol, vol.40, issue.6, pp.15-19, 2013. ,
Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment, Cancer Biol Ther, vol.6, issue.8, pp.1181-1185, 2007. ,
Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model, Head Neck, vol.30, issue.6, pp.782-789, 2008. ,
In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice, Oncol Rep, vol.27, issue.6, pp.1925-1931, 2012. ,
Optical imaging of head and neck squamous cell carcinoma in vivo using arginine-glycine-aspartic acid peptide conjugated near-infrared quantum dots, Onco Targets Ther, vol.6, pp.1779-1787, 2013. ,
Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody, Mol Imaging, vol.11, issue.1, pp.33-46, 2012. ,
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis, Head Neck, vol.34, issue.7, pp.1002-1008, 2012. ,
Immunohistochemical analysis of integrins alphavbeta3, alphavbeta5 and alpha5beta1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas, Exp Ther Med, vol.2, issue.1, pp.9-19, 2011. ,
18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck, Clin Cancer Res, vol.13, pp.6610-6616, 2007. ,
Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin alphavbeta3, Int J Mol Med, vol.27, issue.5, pp.679-687, 2011. ,
Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4, Mol Imaging, vol.5, issue.3, pp.188-197, 2006. ,
In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors, Mol Cancer, vol.6, p.41, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00174215
In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD, Eur J Nucl Med Mol Imaging, vol.34, issue.12, pp.2037-2047, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00176669
New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors, Mol Ther, vol.12, issue.6, pp.1168-1175, 2005. ,
Near-infrared optical guided surgery of highly infiltrative fibrosarcomas in cats using an anti-alphavss3 integrin molecular probe, Cancer Lett, vol.334, issue.2, pp.188-195, 2013. ,
Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model, Br J Surg, vol.97, issue.5, pp.737-743, 2010. ,
Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model, PLoS One, vol.7, issue.2, p.31875, 2012. ,
Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts, Technol Cancer Res Treat, vol.7, issue.1, pp.61-66, 2008. ,
Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate, Mol Imaging, vol.7, issue.1, pp.42-49, 2008. ,
Imageguided surgery in head and neck cancer: current practice and future directions of optical imaging, Head Neck, vol.34, issue.1, pp.120-126, 2012. ,
A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging, Onco Targets Ther, vol.6, pp.325-330, 2013. ,
Considerations in the use of nude mice for cancer research, Cancer Metastasis Rev, vol.3, issue.4, pp.341-360, 1984. ,
Animal models of cancer in the head and neck region, Clin Exp Otorhinolaryngol, vol.2, issue.2, pp.55-60, 2009. ,
Mouse models for human head and neck squamous cell carcinomas, Head Neck, vol.28, issue.10, pp.945-954, 2006. ,
Orthotopic murine model of head and neck squamous cell carcinoma, 2005. ,
, Acta Otorrinolaringol Esp, vol.56, issue.3, pp.89-95
Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model, Ann Surg Oncol, vol.19, issue.12, pp.3879-3887, 2012. ,
Preclinical comparison of near-infraredlabeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma, Mol Imaging Biol, vol.15, issue.6, pp.722-729, 2013. ,
Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer, J Surg Oncol, vol.105, issue.7, pp.714-718, 2012. ,
Use of fluorescent labeled antiepidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts, Mol Cancer Ther, vol.6, issue.4, pp.1230-1238, 2007. ,
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer, Ann Surg Oncol, vol.19, issue.6, pp.1988-1994, 2012. ,
Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping, Mol Imaging, vol.4, issue.3, pp.172-181, 2005. ,
Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation, Bioconjug Chem, vol.21, issue.1, pp.93-101, 2010. ,
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects, Bioconjug Chem, vol.21, issue.5, pp.797-802, 2010. ,